Zai Lab (ZLAB) Revenue & Revenue Breakdown
Zai Lab Revenue Highlights
Latest Revenue (Y)
$460.16M
Latest Revenue (Q)
$106.31M
Main Segment (Y)
Zejula
Zai Lab Revenue by Period
Zai Lab Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $460.16M | 15.33% |
| 2024-12-31 | $398.99M | 49.59% |
| 2023-12-31 | $266.72M | 24.03% |
| 2022-12-31 | $215.04M | 49.01% |
| 2021-12-31 | $144.31M | 194.77% |
| 2020-12-31 | $48.96M | 277.04% |
| 2019-12-31 | $12.98M | 9930.55% |
| 2018-12-31 | $129.45K | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
Zai Lab generated $460.16M in revenue during NA 2025, up 15.33% compared to the previous quarter, and up 939.90% compared to the same period a year ago.
Zai Lab Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $106.31M | 6.73% |
| 2026-03-31 | $99.61M | -21.93% |
| 2025-12-31 | $127.60M | 9.91% |
| 2025-09-30 | $116.09M | 5.56% |
| 2025-06-30 | $109.98M | 3.28% |
| 2025-03-31 | $106.49M | -2.37% |
| 2024-12-31 | $109.07M | 6.65% |
| 2024-09-30 | $102.27M | 1.75% |
| 2024-06-30 | $100.50M | 15.32% |
| 2024-03-31 | $87.15M | 32.38% |
| 2023-12-31 | $65.83M | -4.91% |
| 2023-09-30 | $69.23M | 0.53% |
| 2023-06-30 | $68.86M | 9.66% |
| 2023-03-31 | $62.80M | 0.31% |
| 2022-12-31 | $62.60M | 8.80% |
| 2022-09-30 | $57.54M | 19.44% |
| 2022-06-30 | $48.18M | 3.11% |
| 2022-03-31 | $46.72M | 5.78% |
| 2021-12-31 | $44.17M | 2.48% |
| 2021-09-30 | $43.10M | 16.70% |
| 2021-06-30 | $36.94M | 83.73% |
| 2021-03-31 | $20.10M | 33.19% |
| 2020-12-31 | $15.09M | 3.02% |
| 2020-09-30 | $14.65M | 33.25% |
| 2020-06-30 | $10.99M | 33.79% |
| 2020-03-31 | $8.22M | 76.92% |
| 2019-12-31 | $4.65M | -5.58% |
| 2019-09-30 | $4.92M | 187.69% |
| 2019-06-30 | $1.71M | - |
| 2019-03-31 | $1.71M | 1220.95% |
| 2018-12-31 | $129.45K | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | - |
Zai Lab generated $106.31M in revenue during Q2 2026, up 6.73% compared to the previous quarter, and up 99.83% compared to the same period a year ago.
Zai Lab Revenue Breakdown
Zai Lab Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Qinlock | $35.61M | $28.83M | $19.24M | $14.96M | $11.62M |
| Product and Service, Other | $717.00K | - | - | - | - |
| Nuzyra | $60.84M | $43.20M | $21.66M | $5.20M | $3.00K |
| Optune | $48.33M | $40.48M | $46.97M | $47.32M | $38.90M |
| Zejula | $189.04M | $187.08M | $168.84M | $145.19M | $93.58M |
Zai Lab's latest annual revenue breakdown by segment (product or service), as of Dec 25: Zejula (56.51%), Nuzyra (18.19%), Optune (14.45%), Qinlock (10.65%), and Product and Service, Other (0.21%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qinlock | $9.59M | $8.98M | $9.67M | $8.90M | $8.54M | $8.51M | $22.73M | $6.09M | $4.71M | $5.70M | $7.53M | $1.31M | $5.83M | $5.54M | $623.00K | $2.96M | $2.93M | $4.29M | $4.03K | - |
| Product and Service, Other | $195.00K | $357.00K | - | $92.00K | $342.00K | $283.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Optune | $12.20M | $12.07M | $11.95M | $12.66M | $12.36M | $11.36M | $28.00M | $12.48M | $8.37M | $11.56M | $13.69M | $13.34M | $12.27M | $10.66M | $11.59M | $12.80M | $11.59M | $10.65M | $9.54M | $7.13M |
| Zejula | $32.08M | $29.97M | $56.04M | $42.43M | $41.04M | $49.53M | $141.58M | $45.50M | $41.61M | $41.59M | $42.96M | $42.68M | $42.33M | $39.21M | $34.05M | $29.60M | $29.45M | $28.16M | $23.37M | $12.61M |
| Nuzyra | $17.10M | $16.26M | $16.00M | $15.43M | $14.29M | $15.12M | $33.29M | $9.91M | $6.07M | $5.48M | $4.64M | $5.47M | $1.60M | $1.55M | $1.31M | $742.00K | - | - | - | - |
| Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $367.00K |
Zai Lab's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Zejula (45.08%), Nuzyra (24.03%), Optune (17.15%), Qinlock (13.48%), and Product and Service, Other (0.27%).
Zai Lab Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AAPG | Ascentage Pharma Group | $980.65M | $141.22K |
| ZLAB | Zai Lab | $460.16M | $106.31M |
| TARS | Tarsus Pharmaceuticals | $451.36M | $173.91M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| IDYA | IDEAYA Biosciences | $218.71M | $8.86M |
| XENE | Xenon Pharmaceuticals | $7.50M | - |
| CDTX | Cidara Therapeutics | $1.27M | - |
| IRON | Disc Medicine | - | - |
| APGE | Apogee Therapeutics | - | - |
| SRRK | Scholar Rock | - | - |